CD24 as a Novel Predictive Biomarker in Patients With Hepatocellular Carcinoma: Friend or Foe?

Journal of Investigative Surgery - United Kingdom
doi 10.1080/08941939.2018.1538399
Full Text
Abstract

Available in full text

Categories
Surgery
Date
Authors
Publisher

Informa UK Limited

Related search

Postoperative Adjuvant TACE for Patients of Hepatocellular Carcinoma in AJCC Stage I: Friend or Foe? A Propensity Score Analysis

Oncotarget
Oncology
2017English

Friend or Foe?

Archives of Internal Medicine
2000English

Potassium Binders in Hemodialysis Patients: A Friend or Foe?

Renal Failure
MedicineNephrologyCritical CareIntensive Care Medicine
2013English

Ectomycorrhiza, Friend or Foe?

Ecosystems
Environmental ChemistryEvolutionEcologySystematicsBehavior
2019English

Azathioprine: Friend or Foe?

British Journal of Dermatology
DermatologyMedicine
2019English

Cramster: Friend or Foe?

Physics Teacher
EducationPhysicsAstronomy
2011English

Endotracheal Intubation: Friend or Foe?

BMJ
1986English

Facilitator, Functionary, Friend or Foe?

2016English

Breast Milk: Friend or FOE?

Archives of Disease in Childhood: Fetal and Neonatal Edition
PediatricsGynecologyPerinatologyObstetricsMedicineChild Health
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy